Ariela Noy
AIDS Malignancy Consortium · Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ariela Noy as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:05 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07662928 · Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK StudyAIDS Malignancy Consortium · not yet recruiting · Adult Burkitt Lymphoma · principal investigator
- Ph1NCT05077527 · Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin LymphomaAIDS Malignancy Consortium · recruiting · AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, HIV Infection · principal investigator
- Ph3NCT04212013 · A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone LymphomaMemorial Sloan Kettering Cancer Center · active not recruiting · Marginal Zone Lymphoma · principal investigator
- Early Ph1NCT04139304 · A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaAIDS Malignancy Consortium · recruiting · Plasmablastic Lymphoma, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma · principal investigator
- Ph2NCT03793140 · A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk TranslocationsMemorial Sloan Kettering Cancer Center · completed · Lymphoma, Leukemia · principal investigator
- Early Ph1NCT02966730 · Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial ChemoimmunotherapyMemorial Sloan Kettering Cancer Center · terminated · Follicular Lymphoma, Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2 · principal investigator
- Ph2NCT00392834 · Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's LymphomaAIDS Malignancy Consortium · completed · Lymphoma · study chair
- Ph2NCT00090987 · Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's SarcomaAIDS Malignancy Consortium · completed · Sarcoma · study chair
- Ph3NCT00002445 · Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS PatientsCytran · completed · Sarcoma, Kaposi, HIV Infections · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- HIV-Associated Malignancy Research P30CA008748 · NCI · SLOAN-KETTERING INST CAN RESEARCH · fiscal years 2013 · $238,405 awarded in 2013Same name and institution; not confirmed by an ID
- CLONOTYPIC PCR FOR MINIMAL RESIDUAL DISEASE IN LYMPHOMAK08CA073825 · NCI · SLOAN-KETTERING INST CAN RESEARCH · fiscal years 1998 to 2002 · $86,400 awarded in 2002Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Consortium for Advancing Management and Prevention of Cancer in People with HIVUM1CA121947 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Joseph A. Sparano · fiscal years 2015 to 2026
- AMC OPERATIONS CENTERU01CA070019 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Jeannette Y. Lee · fiscal years 1995 to 2005Named on NCT00392834, NCT00090987
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:05 UTC. The ranking covers the 200 most relevant of 52 PubMed records, and a shared surname and initials can bring in a namesake. All 52 on PubMed
- 332 citationsRCR 6.8
- Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.Cancer Discov · 2017328 citationsRCR 10.8
- 317 citationsRCR 6.5
- Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.Blood · 2012260 citationsRCR 5.8
- 248 citationsRCR 5.6
- Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma.Blood · 2017247 citationsRCR 7.5
- 225 citationsRCR 6.6
- 222 citationsRCR 6.6
- 213 citationsRCR 4.3
- 213 citationsRCR 6.9